27 results
Hepatopulmonary Syndrome (HPS) 

HPS-differential diagnosis:
1. Pulmonary vasculature
2. Diseases of the lung parenchyma
3. Pleura and diaphragm

HPS-diagnosis:
1. Patients
Diseases of the ... lung parenchyma ... and diaphragm HPS-diagnosis ... #HPS #hepatology ... #pulmonary #diagnosis
Hepatopulmonary Syndrome - Diagnosis and Management Summary
A defect in arterial oxygenation due to a gas exchange
Hepatopulmonary Syndrome ... absence of intrinsic lung ... on radioactive lung ... #diagnosis #management ... #treatment #hepatology
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Lung Abscess - Diagnosis ... and Management ... pneumonia • DM risk ... #Abscess #pulmonary ... #treatment #diagnosis
Hemophilia - Diagnosis and Management
Diagnosis:
 • Consistent bleeding history (unless screening for disease in family members
and Management ... Avoid meds that ... ↑ bleeding risk ... #Management #treatment ... #hematology
Common Variable Immunodeficiency (CVID)

What?
CVID: Immunodeficiency disorder with hypogammaglobulinemia -> increased infection risk secondary to impaired B-cell
increased infection risk ... • Chronic lung ... : • Nephrotic syndrome ... (Epstein-Barr syndrome ... #diagnosis #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... Tuberculosis Diagnosis ... Inhibitor: • Risk ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
Syndromes - OnePager ... life-threatening diseases ... Inflammatory eye disease ... sparing of the lung ... #management #treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... Tuberculosis Diagnosis ... Inhibitor: • Risk ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
Pulmonary Nodule
Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
yield of available diagnostic ... The treatment of ... artery disease; ... Management options ... with a higher risk
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Differentiation Syndrome ... Triggers: ATRA treatment ... Attempt if high risk ... Imaging: CXR- pulmonary ... #management #hematology